Clinical trial
Multicenter Uveitis Steroid Treatment (MUST) Trial
NCT00132691 · JHSPH Center for Clinical Trials, Other · Completed
Key facts
| NCT number | NCT00132691 |
|---|---|
| Title | Multicenter Uveitis Steroid Treatment (MUST) Trial |
| Official title | Multicenter Uveitis Steroid Treatment (MUST) Trial |
| Acronym | MUST |
| Lead sponsor | JHSPH Center for Clinical Trials, Other |
| Collaborators | National Eye Institute (NEI) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Uveitis |
| Intervention type | Drug |
| Interventions | fluocinolone acetonide intraocular implant, oral corticosteroid with immunosuppressive agents as needed |
| Enrollment | 255 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Aug 22, 2005 |
| Last update posted | Nov 25, 2016 |
| Countries | Australia, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: